Cleared Traditional

FAST1™ Intraosseous Infusion System (K180588) - FDA 510(k) Clearance

Also marketed or referenced as:
FASTResponder™ Sternal Intraosseous Device

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180588 · Teleflex Medical · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2018
Decision
42d
Days
Class 2
Risk

K180588 is an FDA 510(k) clearance for the FAST1™ Intraosseous Infusion System. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Teleflex Medical (Morrisville, US). The FDA issued a Cleared decision on April 17, 2018 after a review of 42 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Teleflex Medical devices

Submission Details

510(k) Number K180588 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2018
Decision Date April 17, 2018
Days to Decision 42 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 129d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 202
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K180588.
Sterile Hypodermic Needle for Single Use
K180259 · Jiangsu Shenli Medical Production Co., Ltd. · May 2018
RELI Safety Blood Collection Tube Holder, RELI Blood Collection Tube Holder
K173279 · Myco Medical Supplies, Inc. · May 2018
VACUETTE EVOPROTECT Safety Blood Collection / Infusion Set
K173757 · Greiner Bio-One Na, Inc. · Apr 2018
DROPLET PEN NEEDLE
K171982 · Htl-Strefa S.A · Mar 2018
NovoFine 32G Tip (0.23/0.25) x 6 mm ETW (extra thin wall)
K173479 · Novo Nordisk, Inc. · Jan 2018
BD Pen Needle
K162516 · Becton, Dickinson and Company · Dec 2016